RxDoctor Payments Data

Nikoloz Shekiladze, MD

Interventional Cardiology · Atlanta, GANPI 1568845147

Payments from drug & device makers

What this record shows

This record is dominated by grants: $74,378 of the $107,850 with a category attached, or 69.0%. 17 manufacturers reported payments, led by Edwards Lifesciences at 46.1% of the total. Reporting peaked in 2023 at $49,535 and has fallen 89.6% since, to $5,166 in 2025. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$107,850in general payments, 2019–2025

Across 324 payments — averaging $332.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$50K
  • Medtronic$24K
  • Abbott$17K
  • Abiomed$4K
  • Penumbra, Inc.$3K
  • W. L. Gore & Associates, Inc.$3K
  • plus $7K from 11 others

What the payments were for

  • Grants$74,37869%
  • Travel & lodging$15,02814%
  • Food & beverage$18,18617%
  • Education$2580%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences52$49,755
Medtronic(2 entities)84$23,854
Abbott39$17,458
Abiomed11$3,634
Penumbra, Inc.24$3,285
W. L. Gore & Associates, Inc.26$2,577
Boston Scientific42$2,408
Inari Medical, Inc.9$1,202
Shockwave Medical, Inc13$1,113
Asahi Intecc USA, Inc.10$945
Biotronik Inc.6$721
Teleflex LLC3$348
Stryker1$142
Thrombolex, Inc.1$120
Cardiovascular Systems Inc.1$100
Philips North America LLC1$100
Verge Medical, Inc.1$88

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$107,850 in reported general payments places this provider in the 90th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia

Medicare billing

Part B allowed, 2024
$92,572
Medicare patients
241
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate12$207
ClopidogrelClopidogrel Bisulfate15$111
Atorvastatin Calcium14$77
Metoprolol Tartrate11$6

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →